Back to Search
Start Over
FDA approves addition of new warnings to hep C drug label
- Source :
- Drug Topics. July, 2015, Vol. 159 Issue 7, p44, 2 p.
- Publication Year :
- 2015
-
Abstract
- FDA has approved label changes for the hepatitis C antiviral simeprevir (Olysio; Janssen) that will include new warnings about serious symptomatic bradycardia--slowing of the heart rate--when the drug is coadministered [...]
Details
- Language :
- English
- ISSN :
- 00126616
- Volume :
- 159
- Issue :
- 7
- Database :
- Gale General OneFile
- Journal :
- Drug Topics
- Publication Type :
- Periodical
- Accession number :
- edsgcl.425237733